Januvia / Byetta Lawsuit Hotline Established:
Toll Free: 1-800-397-4046
Toll Free: 1-800-397-4046
The Taxotere lawsuit has alleged the makers of the populare chemotherapy drug used to fight breast cancer among others cancers failed to warn women of the side effects and risk for permanent alopecia (loss of hair).
Other possible side effects include:
Investigating attorneys allege the manufacturers knew about a permanent hair loss rate of up to 10% occurring in Phase II clinical trials in 2005, but failed to update the labels and warn patients until 2016.
The FDA adverse reactions list includes reported cases of permanent scalp alopecia resulting from use.
You may be entitled to significant legal compensation, if you suffered hair loss longer than 6 months after treatment, contact us immediately to learn your legal options..
The Food & Drug has listed reported cases of permanent alopecia, but what other scientific studies support a causal link between taking the chemotherapy drug?.
Long Term Hair Loss: The NCRI Cancer Converence found participants with early breast cancer who were given docetaxel (Taxotere) had a 15.8% rate of persistent scalp hair loss with a number of patients reporting loss of eyebrows with no regrowth, losee of eyelash hair, nostril hair and leg hair with no regrowth of the affected areas and study patients reported a significant impact on their quality of life as result of the adverse effects suffered. You can read more about this study here (NCRI).
Chemo Induced Alopecia: The manufacturer of the Taxotere, Sanofi-Aventis, has stated that permanent loss of hair is rare. However, the manufacturer reported an incidence rate of 9.2% for long term hair loss to the EMA in 2005. However, Taxotere litigation filed cites their failure to warn patients properly of the risks and not having updated the label of side effects. The Phase II safety study information can be found here.
Permanent Scalp Alopecia: Additionally, a 20 person study was conducted, published in the Annals of Oncology, on caucasian females with hair loss in which no spontaneous regrowth of scalp hair was noted in the affected women who were being treated for breast cancer with a docetaxel regimen. The biopsy and study ruled out causal factors such as iron or zinc deficiency, thyroid disorders and hyperandrogenism. Treatments to regrow the hair proved ineffective, the baldness found to be permanent. You can view the data here.
Despite the recently reported findings, the manufacture has not issued a Taxotere recall at this time over alopecia risks, our dangerous drug attorney investigation is still in the early stages. A pending Taxotere suit has been filed, and our product liability lawyer expects the number of women who come forward who have been affected and wish to file suit to grow as more information becomes public.
You are limited in the time you have to file a Taxotere claim, it is vital that you act now. Depending on when you suffered your potentially Taxotere caused injuries your time may be running out. The statute of limitation in your state may restrict your ability to file a claim if you don't act now..
If you suffered hair loss longer than 6 months following the end of your treatment, contact us immediately to speak with a Taxotere attorney about your legal options. No obligation, no costs to you unless you win compensation.
You may be entitled to significant compensation, contact one of our award winning attorneys handling Taxotere litigation now.